|
1
|
Roberts CM, Levi M, McKee M, Schilling R,
Lim WS and Grocott MPW: COVID-19: A complex multisystem disorder.
Br J Anaesth. 125:238–242. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chacko M, Job A, Caston F III, George P,
Yacoub A and Cáceda R: COVID-19-induced psychosis and suicidal
behavior: Case report. SN Compr Clin Med. 26:1–5. 2020.PubMed/NCBI
|
|
3
|
Ferrando SJ, Klepacz L, Lynch S, Tavakkoli
M, Dornbush R, Baharani R, Smolin Y and Bartell A: COVID-19
psychosis: A potential new neuropsychiatric condition triggered by
novel coronavirus infection and the inflammatory response?
Psychosomatics. 6:551–555. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mazza MG, De Lorenzo R, Conte C, Poletti
S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F,
Rovere-Querini P, et al: Anxiety and depression in COVID-19
survivors: Role of inflammatory and clinical predictors. Brain
Behav Immun. 89:594–600. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anjum S, Ullah R, Rana MS, Khan HA, Memon
FS, Ahmed Y, Jabeen S and Faryal R: COVID-19 pandemic: A serious
threat for public mental health globally. Psychiatr Danub.
32:245–250. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Khoury F, Cuenca M, Niel P and Masson
VD: Low prevalence of SARS-CoV-2 among patients presenting at a
Parisian psychiatry University Hospital Group. Eur J Psychiatry.
Sep 24–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee SW, Yang JM, Moon SY, Yoo IK, Ha EK,
Kim SY, Park UM, Choi S, Lee SH, Ahn YM, et al: Association between
mental illness and COVID-19 susceptibility and clinical outcomes in
South Korea: A nationwide cohort study. Lancet Psychiatry.
7:1025–1031. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
DiMatteo MR, Lepper HS and Croghan TW:
Depression is a risk factor for noncompliance with medical
treatment: Meta-analysis of the effects of anxiety and depression
on patient adherence. Arch Intern Med. 160:2101–2107. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nicholson A, Kuper H and Hemingway H:
Depression as an aetiologic and prognostic factor in coronary heart
disease: A meta-analysis of 6362 events among 146 538 participants
in 54 observational studies. Eur Heart J. 27:2763–2774. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alpert O, Begun L, Garren P and Solhkhah
R: Cytokine storm induced new onset depression in patients with
COVID-19. A new look into the association between depression and
cytokines-two case reports. Brain Behav Immun Health. 9:1001732020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maugeri G, Castrogiovanni P, Battaglia G,
Pippi R, D'Agata V, Palma A, Di Rosa M and Musumeci G: The impact
of physical activity on psychological health during Covid-19
pandemic in Italy. Heliyon. 6:e043152020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ravalli S and Musumeci G: Coronavirus
outbreak in Italy: Physiological benefits of home-based exercise
during pandemic. J Funct Morphol Kinesiol. 5:312020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maugeri G and Musumeci G: Adapted physical
activity to ensure the physical and psychological well-being of
COVID-19 patients. J Funct Morphol Kinesiol. 6:132021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weir EK, Thenappan T, Bhargava M and Chen
Y: Does vitamin D deficiency increase the severity of COVID-19?
Clin Med (Lond). 20:e107–e108. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leisman DE, Ronner L, Pinotti R, Taylor
MD, Sinha P, Calfee CS, Hirayama AV, Mastroiani F, Turtle CJ,
Harhay MO, et al: Cytokine elevation in severe and critical
COVID-19: A rapid systematic review, meta-analysis, and comparison
with other inflammatory syndromes. Lancet Respir Med. 8:1233–1244.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goldstein BI, Kemp DE, Soczynska JK and
McIntyre RS: Inflammation and the phenomenology, pathophysiology,
comorbidity, and treatment of bipolar disorder: A systematic review
of the literature. J Clin Psychiatry. 70:1078–1090. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Farooq RK, Asghar K, Kanwal S and
Zulqernain A: Role of inflammatory cytokines in depression: Focus
on interleukin-1β. Biomed Rep. 6:15–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Himmerich H, Patsalos O, Lichtblau N,
Ibrahim MAA and Dalton B: Cytokine research in depression:
Principles, challenges, and open questions. Front Psychiatry.
10:302019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Momtazmanesh S, Zare-Shahabadi A and
Rezaei N: Cytokine alterations in schizophrenia: An updated review.
Front Psychiatry. 10:8922019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Lu H, Zeng H, Zhang S, Du Q,
Jiang T and Du B: The differential psychological distress of
populations affected by the COVID-19 pandemic. Brain Behav Immun.
87:49–50. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stienen MN, Haghikia A, Dambach H, Thöne
J, Wiemann M, Gold R, Chan A, Dermietzel R, Faustmann PM, Hinkerohe
D and Prochnow N: Anti-inflammatory effects of the anticonvulsant
drug levetiracetam on electrophysiological properties of astroglia
are mediated via TGFβ1 regulation. Br J Pharmacol. 162:491–507.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoşgörler F, Keleş D,
Tanrıverdi-Akhisaroğlu S, İnanç Ş, Akhisaroğlu M, Cankurt Ü,
Aydoğdu Z, Uçar AD, Çetinayak O, Oktay G and Arda SG:
Anti-inflammatory and Anti-apoptotic effect of valproic acid and
doxycycline independent from MMP inhibition in early radiation
damage. Balkan Med J. 33:488–495. 2013. View Article : Google Scholar
|
|
23
|
Al-Amin MM, Nasir Uddin MM and Mahmud Reza
H: Effects of antipsychotics on the inflammatory response system of
patients with schizophrenia in peripheral blood mononuclear cell
cultures. Clin Psychopharmacol Neurosci. 11:144–151. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fourrier C, Sampson E, Mills NT and Baune
BT: Anti-inflammatory treatment of depression: Study protocol for a
randomised controlled trial of vortioxetine augmented with
celecoxib or placebo. Trials. 19:4472018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cho M, Lee TY, Kwak YB, Yoon YB, Kim M and
Kwon JS: Adjunctive use of anti-inflammatory drugs for
schizophrenia: A meta-analytic investigation of randomized
controlled trials. Aust N Z J Psychiatry. 53:742–759. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
May M, Slitzky M, Rostama B, Barlow D and
Houseknecht KL: Antipsychotic-induced immune dysfunction: A
consideration for COVID-19 risk. Brain Behav Immun Health.
6:1000972020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Govind R, Fonseca de Freitas D, Pritchard
M, Hayes RD and MacCabe JH: Clozapine treatment and risk of
COVID-19 infection: Retrospective cohort study. Br J Psychiatry.
27:1–7. 2020.PubMed/NCBI
|
|
28
|
Gurrera RJ and Perry NL:
Clozapine-associated aspiration pneumonia: Case series and review
of the literature: Reply. Psychosomatics. 60:1032019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ponsford M, Castle D, Tahir T, Robinson R,
Wade W, Steven R, Bramhall K, Moody M, Carne E, Ford C, et al:
Clozapine is associated with secondary antibody deficiency. Br J
Psychiatry. 214:1–7. 2018.PubMed/NCBI
|
|
30
|
Vancampfort D, Probst M, Daenen A, Damme
TV, De Hert M, Rosenbaum S and Bruyninckx D: Impact of
antipsychotic medication on physical activity and physical fitness
in adolescents: An exploratory study. Psychiatry Res. 242:192–197.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Perez-Cruzado D, Cuesta-Vargas A,
Vera-Garcia E and Mayoral-Cleries F: Medication and physical
activity and physical fitness in severe mental illness. Psychiatry
Res. 267:19–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brailovskaia J, Cosci F, Mansueto G,
Miragall M, Herrero R, Baños RM, Krasavtseva Y, Kochetkov Y and
Margraf J: The association between depression symptoms,
psychological burden caused by Covid-19 and physical activity: An
investigation in Germany, Italy, Russia, and Spain. Psychiatry Res.
295:1135962021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Phillips C: Brain-Derived neurotrophic
factor, depression, and physical activity: Making the neuroplastic
connection. Neural Plast. 2017:72601302017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Köhler-Forsberg O, N Lydholm C, Hjorthøj
C, Nordentoft M, Mors O and Benros ME: Efficacy of
anti-inflammatory treatment on major depressive disorder or
depressive symptoms: Meta-analysis of clinical trials. Acta
Psychiatr Scand. 139:404–419. 2019. View Article : Google Scholar
|
|
35
|
Lenze EJ, Mattar C, Zorumski CF, Stevens
A, Schweiger J, Nicol GE, Miller JP, Yang L, Yingling M, Avidan MS
and Reiersen AM: Fluvoxamine vs placebo and clinical deterioration
in outpatients with symptomatic COVID-19: A randomized clinical
trial. JAMA. 324:2292–2300. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ishima T, Fujita Y and Hashimoto K:
Interaction of new antidepressants with sigma-1 receptor chaperones
and their potentiation of neurite outgrowth in PC12 cells. Eur J
Pharmac. 727:167–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Homolak J and Kodvanj I: Widely available
lysosome targeting agents should be considered as potential therapy
for COVID-19. Int J Antimicrob Agents. 56:1060442020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nadkarni S and Devinsky O: Psychotropic
effects of antiepileptic drugs. Epilepsy Curr. 5:176–181. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grunze HC: The effectiveness of
anticonvulsants in psychiatric disorders. Dialogues Clin Neurosci.
10:77–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aranow C: Vitamin D and the immune system.
J Investig Med. 59:881–886. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Menon B and Harinarayan CV: The effect of
anti epileptic drug therapy on serum 25-hydroxyvitamin D and
parameters of calcium and bone metabolism-a longitudinal study.
Seizure. 19:153–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Teagarden DL, Meador KJ and Loring DW: Low
vitamin D levels are common in patients with epilepsy. Epilepsy
Res. 108:1352–1356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chaudhuri JR, Mridula KR, Rathnakishore C,
Balaraju B and Bandaru VS: Association of 25-Hydroxyvitamin D
Deficiency in pediatric epileptic patients. Iran J Child Neurol.
11:48–56. 2017.PubMed/NCBI
|
|
44
|
Mariani J, Giménez VMM, Bergam I, Tajer C,
Antonietti L, Inserra F, Ferder L and Manucha W: Association
between vitamin D deficiency and COVID-19 incidence, complications,
and mortality in 46 countries: An ecological study. Health Secur.
19:302–308. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jain A, Chaurasia R, Sengar NS, Singh M,
Mahor S and Narain S: Analysis of vitamin D level among
asymptomatic and critically ill COVID-19 patients and its
correlation with inflammatory markers. Sci Rep. 10:201912020.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Entrenas Castillo M, Entrenas Costa LM,
Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R and
Quesada Gomez JM: ‘Effect of calcifediol treatment and best
available therapy versus best available therapy on intensive care
unit admission and mortality among patients hospitalized for
COVID-19: A pilot randomized clinical study’. J Steroid Biochem Mol
Biol. 203:1057512020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tan CW, Ho LP, Kalimuddin S, Cherng BPZ,
Teh YE, Thien SY, Wong HM, Tern PJW, Chandran M, Chay JWM, et al:
Cohort study to evaluate the effect of vitamin D, magnesium, and
vitamin B12 in combination on progression to severe
outcomes in older patients with coronavirus (COVID-19). Nutrition.
79-80:1110172020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jakovac H: COVID-19 and vitamin D-Is there
a link and an opportunity for intervention? Am J Physiol Endocrinol
Metab. 318:E5892020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ahmed F: A network-based analysis reveals
the mechanism underlying vitamin D in suppressing cytokine storm
and virus in SARS-CoV-2 infection. Front Immunol. 11:5904592020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Aygun H: Vitamin D can prevent COVID-19
infection-induced multiple organ damage. Naunyn Schmiedebergs Arch
Pharmacol. 393:1157–1160. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kumar R, Rathi H, Haq A, Wimalawansa SJ
and Sharma A: Putative roles of vitamin D in modulating immune
response and immunopathology associated with COVID-19. Virus Res.
292:1982352021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Verdoia M, Pergolini P, Nardin M, Rolla R,
Negro F, Kedhi E, Suryapranata H, Marcolongo M, Carriero A and De
Luca G; Novara Atherosclerosis Study Group (NAS), : Vitamin D
levels and platelet reactivity in diabetic patients receiving dual
antiplatelet therapy. Vascul Pharmacol. 120:1065642019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zabetakis I, Lordan R, Norton C and
Tsoupras A: COVID-19: The inflammation link and the role of
nutrition in potential mitigation. Nutrients. 12:14662020.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
McCreadie RG; Scottish Schizophrenia
Lifestyle Group, : Diet, smoking and cardiovascular risk in people
with schizophrenia: Descriptive study. Br J Psychiatry.
183:534–539. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Henderson DC, Borba CP, Daley TB, Boxill
R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A,
Freudenreich O, et al: Dietary intake profile of patients with
schizophrenia. Ann Clin Psychiatry. 18:99–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Amani R: Is dietary pattern of
schizophrenia patients different from healthy subjects? BMC
Psychiatry. 7:152007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dipasquale S, Pariante CM, Dazzan P,
Aguglia E, McGuire P and Mondelli V: The dietary pattern of
patients with schizophrenia: A systematic review. J Psychiatr Res.
47:197–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Firth J, Stubbs B, Teasdale SB, Ward PB,
Veronese N, Shivappa N, Hebert JR, Berk M, Yung AR and Sarris J:
Diet as a hot topic in psychiatry: A population-scale study of
nutritional intake and inflammatory potential in severe mental
illness. World Psychiatry. 17:365–367. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Teasdale SB, Ward PB, Samaras K, Firth J,
Stubbs B, Tripodi E and Burrows TL: Dietary intake of people with
severe mental illness: Systematic review and meta-analysis. Br J
Psychiatry. 214:251–259. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Milanski M, Degasperi G, Coope A, Morari
J, Denis R, Cintra DE, Tsukumo DM, Anhe G, Amaral ME, Takahashi HK,
et al: Saturated fatty acids produce an inflammatory response
predominantly through the activation of TLR4 signaling in
hypothalamus: Implications for the pathogenesis of obesity. J
Neurosci. 29:359–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Patterson E, Wall R, Fitzgerald GF, Ross
RP and Stanton C: Health implications of high dietary omega-6
polyunsaturated Fatty acids. J Nutr Metab. 2012:5394262012.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jump DB, Botolin D, Wang Y, Xu J and
Christian B: Fatty acids and gene transcription. Food Nutr Res. 50
(Suppl 2):5–12. 2006. View Article : Google Scholar
|
|
63
|
Stienstra R, Duval C, Müller M and Kersten
S: PPARs, obesity, and inflammation. PPAR Res. 2007:959742007.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Muralikumar S, Vetrivel U, Narayanasamy A
and N Das U: Probing the intermolecular interactions of PPARγ-LBD
with polyunsaturated fatty acids and their anti-inflammatory
metabolites to infer most potential binding moieties. Lipids Health
Dis. 16:172017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Choi GJ, Kim HM and Kang H: The potential
role of dyslipidemia in COVID-19 severity: An umbrella review of
systematic reviews. J Lipid Atheroscler. 9:435–448. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Perona JS: Membrane lipid alterations in
the metabolic syndrome and the role of dietary oils. Biochim
Biophys Acta Biomembr. 1859 (9 Pt B). 1690–1703. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Oruch R, Lund A, Pryme IF and Holmsen H:
An intercalation mechanism as a mode of action exerted by
psychotropic drugs: Results of altered phospholipid substrate
availabilities in membranes? J Chem Biol. 3:67–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Leguisamo NM, Lehnen AM, Machado UF,
Okamoto MM, Markoski MM, Pinto GH and Schaan BD: GLUT4 content
decreases along with insulin resistance and high levels of
inflammatory markers in rats with metabolic syndrome. Cardiovasc
Diabetol. 11:1002012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Bousquet J, Anto JM, Iaccarino G,
Czarlewski W, Haahtela T, Anto A, Akdis CA, Blain H, Canonica GW,
Cardona V, et al: Is diet partly responsible for differences in
COVID-19 death rates between and within countries? Clin Transl
Allergy. 10:162020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Jakovac H: COVID-19: Is the ACE2 just a
foe? Am J Physiol Lung Cell Mol Physiol. 318:L1025–L1026. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Warner FJ, Rajapaksha H, Shackel N and
Herath CB: ACE2: From protection of liver disease to propagation of
COVID-19. Clin Sci (Lond). 134:3137–3158. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Gohil K, Samson R, Dastager S and Dharne
M: Probiotics in the prophylaxis of COVID-19: Something is better
than nothing. 3 Biotech. 11:12021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Karl JP: Gut Microbiota-targeted
interventions for reducing the incidence, duration, and severity of
respiratory tract infections in healthy non-elderly adults. Mil
Med. 186:e310–e318. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hamida RS, Shami A, Ali MA, Almohawes ZN,
Mohammed AE and Bin-Meferij MM: Kefir: A protective dietary
supplementation against viral infection. Biomed Pharmacother.
133:1109742021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Abdulah DM and Hassan AB: Relation of
dietary factors with infection and mortality rates of COVID-19
across the World. J Nutr Health Aging. 24:1011–1018. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Falagas ME and Kompoti M: Obesity and
infection. Lancet Infect Dis. 6:438–446. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Karlsson EA and Beck MA: The burden of
obesity on infectious disease. Exp Biol Med (Maywood).
235:1412–1424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Li P, Yin YL, Li D, Kim SW and Wu G: Amino
acids and immune function. Br J Nutr. 98:237–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Jenkins DJA, Srichaikul KK, Kendall CWC
and Sievenpiper JL: Bean, fruit, and vegetable fiber, but not
cereal fiber are associated with reduced mortality in Japan. Am J
Clin Nutr. 111:941–943. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gill SK, Rossi M, Bajka B and Whelan K:
Dietary fibre in gastrointestinal health and disease. Nat Rev
Gastroenterol Hepatol. 18:101–116. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Yao T, Chen MH and Lindemann SR:
Structurally complex carbohydrates maintain diversity in
gut-derived microbial consortia under high dilution pressure. FEMS
Microbiol Ecol. 96:fiaa1582020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Vanable PA, Carey MP, Carey KB and Maisto
SA: Smoking among psychiatric outpatients: Relationship to
substance use, diagnosis, and illness severity. Psychol Addict
Behav. 17:259–265. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
de Leon J and Diaz FJ: A meta-analysis of
worldwide studies demonstrates an association between schizophrenia
and tobacco smoking behaviors. Schizophr Res. 76:135–157. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Gilbody S, Peckham E, Bailey D, Arundel C,
Heron P, Crosland S, Fairhurst C, Hewitt C and Li J; members of the
SCIMITAR+ collaborative, : Smoking cessation in severe mental
illness: Combined long-term quit rates from the UK SCIMITAR trials
programme. Br J Psychiatry. 18:95–97. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Thomson D, Berk M, Dodd S, Rapado-Castro
M, Quirk SE, Ellegaard PK, Berk L and Dean OM: Tobacco use in
bipolar disorder. Clin Psychopharmacol Neurosci. 13:1–11. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li XH, An FR, Ungvari GS, Ng CH, Chiu HFK,
Wu PP, Jin X and Xiang YT: Prevalence of smoking in patients with
bipolar disorder, major depressive disorder and schizophrenia and
their relationships with quality of life. Sci Rep. 7:84302017.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Arnson Y, Shoenfeld Y and Amital H:
Effects of tobacco smoke on immunity, inflammation and
autoimmunity. J Autoimmun. 34:J258–J265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lee J, Taneja V and Vassallo R: Cigarette
smoking and inflammation: Cellular and molecular mechanisms. J Dent
Res. 91:142–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Cattaruzza MS, Zagà V, Gallus S, D'Argenio
P and Gorini G: Tobacco smoking and COVID-19 pandemic: Old and new
issues. A summary of the evidence from the scientific literature.
Acta Biomed. 91:106–112. 2020.PubMed/NCBI
|
|
91
|
Polverino F: Cigarette smoking and
COVID-19: A complex interaction. Am J Respir Crit Care Med.
202:471–472. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Reddy RK, Charles WN, Sklavounos A, Dutt
A, Seed PT and Khajuria A: The effect of smoking on COVID-19
severity: A systematic review and meta-analysis. J Med Virol.
93:1045–1056. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lombardi C, Roca E, Ventura L and Cottini
M: Smoking and COVID-19, the paradox to discover: An Italian
retrospective, observational study in hospitalized and
non-hospitalized patients. Med Hypotheses. 146:1103912021.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Usman MS, Siddiqi TJ, Khan MS, Patel UK,
Shahid I, Ahmed J, Kalra A and Michos ED: Is there a smoker's
paradox in COVID-19? BMJ Evid Based Med. Aug 11–2020.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Edmonston DL, South AM, Sparks MA and
Cohen JB: Coronavirus disease 2019 and hypertension: The role of
angiotensin-converting enzyme 2 and the renin-angiotensin system.
Adv Chronic Kidney Dis. 27:404–411. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Vleeming W, Rambali B and Opperhuizen A:
The role of nitric oxide in cigarette smoking and nicotine
addiction. Nicotine Tob Res. 4:341–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Akerström S, Mousavi-Jazi M, Klingström J,
Leijon M, Lundkvist A and Mirazimi A: Nitric oxide inhibits the
replication cycle of severe acute respiratory syndrome coronavirus.
J Virol. 79:1966–1969. 2005. View Article : Google Scholar
|
|
98
|
Czuczwar M, Kiś J, Czuczwar P, Wielosz M
and Turski W: Nicotine diminishes anticonvulsant activity of
antiepileptic drugs in mice. Pol J Pharmacol. 55:799–802.
2003.PubMed/NCBI
|
|
99
|
Reinsberger C, Dorn T and Krämer G:
Smoking reduces serum levels of lamotrigine. Seizure. 17:651–653.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Tsuda Y, Saruwatari J and Yasui-Furukori
N: Meta-analysis: The effects of smoking on the disposition of two
commonly used antipsychotic agents, olanzapine and clozapine. BMJ
Open. 4:e0042162014. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Oliveira P, Ribeiro J, Donato H and
Madeira N: Smoking and antidepressants pharmacokinetics: A
systematic review. Ann Gen Psychiatry. 16:172017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Bobes J, Arango C, Garcia-Garcia M and
Rejas J: Healthy lifestyle habits and 10-year cardiovascular risk
in schizophrenia spectrum disorders: An analysis of the impact of
smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res.
119:101–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Chao AM, White MA, Grilo CM and Sinha R:
Examining the effects of cigarette smoking on food cravings and
intake, depressive symptoms, and stress. Eat Behav. 24:61–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Alsuwaidan MT, Kucyi A, Law CW and
McIntyre RS: Exercise and bipolar disorder: A review of
neurobiological mediators. Neuromolecular Med. 11:328–336. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Sylvia LG, Ametrano RM and Nierenberg AA:
Exercise treatment for bipolar disorder: Potential mechanisms of
action mediated through increased neurogenesis and decreased
allostatic load. Psychother Psychosom. 79:87–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kay-Lambkin FJ, Thornton L, Lappin JM,
Hanstock T, Sylvia L, Jacka F, Baker AL, Berk M, Mitchell PB,
Callister R, et al: Study protocol for a systematic review of
evidence for lifestyle interventions targeting smoking, sleep,
alcohol/other drug use, physical activity, and healthy diet in
people with bipolar disorder. Syst Rev. 5:1062016. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Cuomo A, Giordano N, Goracci A and
Fagiolini A: Depression and vitamin D deficiency: Causality,
assessment, and clinical practice implications. Neuropsychiatry
(London). 7:606–614. 2017.
|
|
108
|
Cuomo A, Maina G, Bolognesi S, Rosso G,
Beccarini Crescenzi B, Zanobini F, Goracci A, Facchi E, Favaretto
E, Baldini I, et al: Prevalence and correlates of vitamin D
deficiency in a sample of 290 inpatients with mental Illness. Front
Psychiatry. 10:1672019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Hansdottir S, Monick MM, Lovan N, Powers
LS and Hunninghake GW: Smoking disrupts vitamin D metabolism in the
lungs. Am J Respir Crit Care Med. 181:A14252010.
|
|
110
|
Lange NE, Sparrow D, Vokonas P and
Litonjua AA: Vitamin D deficiency, smoking, and lung function in
the normative aging study. Am J Respir Crit Care Med. 186:616–621.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Uh ST, Koo SM, Kim YK, Kim KU, Park SW,
Jang AS, Kim DJ, Kim YH and Park CS: Inhibition of vitamin D
receptor translocation by cigarette smoking extracts. Tuberc Respir
Dis (Seoul). 73:258–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Gejman PV, Sanders AR and Duan J: The role
of genetics in the etiology of schizophrenia. Psychiatr Clin North
Am. 33:35–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Kerner B: Genetics of bipolar disorder.
Appl Clin Genet. 7:33–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Shadrina M, Bondarenko EA and Slominsky
PA: Genetics factors in major depression disease. Front Psychiatry.
9:3342018. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Kaser A: Genetic risk of severe covid-19.
N Engl J Med. 383:1590–1591. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Pairo-Castineira E, Clohisey S, Klaric L,
Bretherick AD, Rawlik K, Pasko D, Walker S, Parkinson N, Fourman
MH, Russell CD, et al: Genetic mechanisms of critical illness in
Covid-19. Nature. 591:92–98. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zeberg H and Pääbo S: The major genetic
risk factor for severe COVID-19 is inherited from Neanderthals.
Nature. 587:610–612. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Rigat B, Hubert C, Alhenc-Gelas F, Cambien
F, Corvol P and Soubrier F: An insertion/deletion polymorphism in
the angiotensin I-converting enzyme gene accounting for half the
variance of serum enzyme levels. J Clin Invest. 86:1343–1346. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Wu Y, Wang X, Shen X, Tan Z and Yuan Y:
The I/D polymorphism of angiotensin-converting enzyme gene in major
depressive disorder and therapeutic outcome: A case-control study
and meta-analysis. J Affect Disord. 136:971–978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Kucukali CI, Aydin M, Ozkok E, Bilge E,
Zengin A, Cakir U and Kara I: Angiotensin-converting enzyme
polymorphism in schizophrenia, bipolar disorders, and their
first-degree relatives. Psychiatr Genet. 20:14–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Mazaheri H and Saadat M: Association
between insertion/deletion polymorphism in angiotension converting
enzyme and susceptibility to schizophrenia. Iran J Public Health.
44:369–373. 2015.PubMed/NCBI
|
|
122
|
Crescenti A, Gassó P, Mas S, Abellana R,
Deulofeu R, Parellada E, Bernardo M and Lafuente A:
Insertion/deletion polymorphism of the angiotensin-converting
enzyme gene is associated with schizophrenia in a Spanish
population. Psychiatry Res. 165:175–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Song GG and Lee YH: The insertion/deletion
polymorphism in the angiotensin-converting enzyme and
susceptibility to schizophrenia or Parkinson's disease: A
meta-analysis. J Renin Angiotensin Aldosterone Syst. 16:434–442.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Nadalin S, Buretić-Tomljanović A, Rubeša
G, Jonovska S, Tomljanović D and Ristić S: Angiotensin-converting
enzyme gene insertion/deletion polymorphism is not associated with
schizophrenia in a Croatian population. Psychiatr Genet.
22:267–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Hui L, Wu JQ, Zhang X, Lv J, Du WL, Kou
CG, Yu YQ, Lv MH, Chen DC and Zhang XY: Association between the
angiotensin-converting enzyme gene insertion/deletion polymorphism
and first-episode patients with schizophrenia in a Chinese Han
population. Hum Psychopharmacol. 29:274–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Hui L, Wu JQ, Ye MJ, Zheng K, He JC, Zhang
X, Liu JH, Tian HJ, Gong BH, Chen DC, et al: Association of
angiotensin-converting enzyme gene polymorphism with schizophrenia
and depressive symptom severity in a Chinese population. Hum
Psychopharmacol. 30:100–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Baghai TC, Schule C, Zwanzger P, Minov C,
Zill P, Ella R, Eser D, Oezer S, Bondy B and Rupprecht R:
Hypothalamic-pituitary-adrenocortical axis dysregulation in
patients with major depression is influenced by the
insertion/deletion polymorphism in the angiotensin I-converting
enzyme gene. Neurosci Lett. 328:299–303. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Bahramali E, Firouzabadi N, Yavarian I,
Shayesteh MR, Erfani N, Shoushtari AA and Asadpour R: Influence of
ACE gene on differential response to sertraline versus fluoxetine
in patients with major depression: A randomized controlled trial.
Eur J Clin Pharmacol. 72:1059–1064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Delanghe JR, Speeckaert MM and De Buyzere
M: The host's angiotensin-converting enzyme polymorphism may
explain epidemiological findings in COVID-19 infections. Clin Chim
Acta. 505:192–193. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Delanghe JR, Speeckaert MM and De Buyzere
ML: COVID-19 infections are also affected by human ACE1 D/I
polymorphism. Clin Chem Lab Med. 58:1125–1126. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zajc Petranović M, Skarić-Jurić T, Smolej
Narančić N, Tomas Z, Krajačić P, Miličić J, Barbalić M and
Tomek-Roksandić S: Angiotensin-converting enzyme deletion allele is
beneficial for the longevity of Europeans. Age (Dordr). 34:583–595.
2012. View Article : Google Scholar
|
|
132
|
Bellone M and Calvisi SL: ACE
polymorphisms and COVID-19-related mortality in Europe. J Mol Med
(Berl). 98:1505–1509. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Hatami N, Ahi S, Sadeghinikoo A,
Foroughian M, Javdani F, Kalani N, Fereydoni M, Keshavarz P and
Hosseini A: Worldwide ACE (I/D) polymorphism may affect COVID-19
recovery rate: An ecological meta-regression. Endocrine.
68:479–484. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Jakovac H: COVID-19 and hypertension: Is
the HSP60 culprit for the severe course and worse outcome? Am J
Physiol Heart Circ Physiol. 319:H793–H796. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Meng J, Xiao G, Zhang J, He X, Ou M, Bi J,
Yang R, Di W, Wang Z, Li Z, et al: Renin-angiotensin system
inhibitors improve the clinical outcomes of COVID-19 patients with
hypertension. Emerg Microbes Infect. 9:757–760. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Pirola CJ and Sookoian S: Estimation of
Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on
COVID-19 outcome: A Meta-analysis. J Infect. 81:276–281. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Zhong Y, Zhao L, Wu G, Hu C, Wu C, Xu M,
Dong H, Zhang Q, Wang G, Yu B, et al: Impact of renin-angiotensin
system inhibitors use on mortality in severe COVID-19 patients with
hypertension: A retrospective observational study. J Int Med Res.
48:3000605209791512020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Cetinkal G, Kocas BB, Ser OS, Kilci H,
Yildiz SS, Ozcan SN, Verdi Y, Altinay M and Kilickesmez K: The
association between chronic use of renin-angiotensin-aldosterone
system blockers and in-hospital adverse events among covid-19
patients with hypertension. Sisli Etfal Hastan Tip Bul. 54:399–404.
2020.PubMed/NCBI
|
|
139
|
Lee MMY, Docherty KF, Sattar N, Mehta N,
Kalra A, Nowacki AS, Solomon SD, Vaduganathan M, Petrie MC, Jhund
PS and McMurray JJV: Renin-angiotensin system blockers, risk of
SARS-CoV-2 infection and outcomes from CoViD-19: Systematic review
and meta-analysis. Eur Heart J Cardiovasc Pharmacother pvaa138.
2020.(Epub ahead of prin). View Article : Google Scholar
|
|
140
|
Niederhofer H: Angiotensin converting
enzyme inhibitors/estrogen/cortisol: Maybe an additional option in
the treatment of psychiatrically disordered patients? Med
Hypotheses. 70:703–704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Gadelha A, Vendramini AM, Yonamine CM,
Nering M, Berberian A, Suiama MA, Oliveira V, Lima-Landman MT,
Breen G, Bressan RA, et al: Convergent evidences from human and
animal studies implicate angiotensin I-converting enzyme activity
in cognitive performance in schizophrenia. Transl Psychiatry.
5:e6912015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Wincewicz D and Braszko JJ: Validation of
brain angiotensin system blockade as a novel drug target in
pharmacological treatment of neuropsychiatric disorders.
Pharmacopsychiatry. 50:233–247. 2017. View Article : Google Scholar : PubMed/NCBI
|
